CH:PPGN Stock Latest News
Company AnnouncementsPolyPeptide Clears Governance Hurdles Ahead of Samsung Tender Offer5d ago
Company AnnouncementsSamsung Biologics Nears Control of PolyPeptide With Successful Tender Offer2w ago
Company AnnouncementsSamsung Biologics Nears Control of PolyPeptide After Strong Tender Uptake2w ago
The FlyPolyPeptide downgraded to Neutral from Buy at UBS3w ago
Company AnnouncementsPolyPeptide Calls Extraordinary Meeting on Samsung Biologics Tender Offer1M ago
Company AnnouncementsSamsung Peptide Launches CHF 1.46 Billion Tender Offer for PolyPeptide2M ago
Company AnnouncementsPolyPeptide lifts 2026 outlook after strong H1 surge in peptide demand2M ago
Company AnnouncementsSamsung Biologics Moves to Acquire Fast‑Growing Peptide CDMO PolyPeptide3M ago
Company AnnouncementsPolyPeptide shareholders back all proposals at 2026 AGM6M ago
Company AnnouncementsPolyPeptide expands EUR 200 million credit line to back growth and capacity plans7M ago
Company AnnouncementsPolyPeptide Sets 2026 AGM to Confirm Board and Approve 2025 Reports7M ago
Company AnnouncementsPolyPeptide lifts revenue and margins as peptide demand fuels major capacity build-out7M agoCompany AnnouncementsPolyPeptide lifts revenue and margins in 2025 as GLP-1 demand powers growth9M ago






